drugset

drugset / Trial / NCT00203463

Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD)

NCT00203463 ↗

Phase 4 Completed 40 enrolled Tuscaloosa Research & Education Advancement Corporation Ortho-McNeil Janssen Scientific Affairs, LLC · collab

RandomizedSingle-groupDouble-blindTreatment

Summary

To study the potential therapeutic effects of topiramate (Topamax) in the treatment of PTSD.

Timeline

Start: 2001-07
Primary completion: 2004-09
Completion: 2004-09

Publications

Background Berlant JL. Topiramate in posttraumatic stress disorder: preliminary clinical observations. J Clin Psychiatry. 2001;62 Suppl 17:60-3.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Topiramate	Small molecule	25 mg	—

Indications